synta pharmaceuticals corp
(SNTA:NASDAQ GM)
Executive Profile*
Christopher Logothetis M.D.Member of Scientific Advisory Board, Synta Pharmaceuticals Corp. |
| Age | Total Calculated Compensation | This person is connected to 30 board members in 2 different organizations across 2 different industries. See Board Relationships |
| -- | -- |
Background*
Christopher J. Logothetis, MD serves as a Member of Scientific Advisory Board at Synta Pharmaceuticals Corp., and Cougar Biotechnology, Inc. Dr. Logothetis serves as a Professor and Chairman of the Department of Genitourinary Medical Oncology at The University of Texas M. D. Anderson Cancer Center, Houston, Texas and is Principal Investigator of the M. D. Anderson SPORE in Prostate Cancer. He serves as a Director of the Genitourinary Cancer Center and the Prostate Cancer ...
Corporate Headquarters*45 Hartwell AvenueLexington, Massachusetts 02421 United States Phone: 781-274-8200 Fax: 781-274-8228 Board Members Memberships*There is no Board Members Memberships data available.Education*There is no Education data available.Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*There is no Total Compensation data available. |
| Recently Viewed | |||
| SNTA:US | $7.57 USD | +0.26 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| James S. J. Manuso Ph.D., MBA | Chairman of The Board and Chief Executive Officer Astex Pharmaceuticals, Inc. | $1.3M |
| Remi Barbier | Founder, Chairman, Chief Executive Officer and President Pain Therapeutics Inc. | $1.2M |
| John R. Plachetka Pharm D. | Co-Founder, Chairman of the Board, Chief Executive Officer and President POZEN Inc. | $574.5K |
| Michael A. Narachi M.S., M.B.A. | Chief Executive Officer, President and Director Orexigen Therapeutics, Inc. | $1.2M |
| Timothy P. Walbert | Chairman, Chief Executive Officer, President, Chief Executive Officer of Horizon Pharma USA, President of Horizon Pharma USA and Director of Horizon Pharma USA Horizon Pharma, Inc. | $572.0K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact SYNTA PHARMACEUTICALS CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
